Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | LIMK1 | P53667 | 4/20 | 0.41 |
| ▸ | EGFR | P00533 | 5/20 | 0.38 |
| ▸ | CDK5 | Q00535 | 1/20 | 0.37 |
| ▸ | CDK5R1 | Q15078 | 1/20 | 0.37 |
| ▸ | CDC7 | O00311 | 1/20 | 0.36 |
| ▸ | CLK1 | P49759 | 1/20 | 0.36 |
| ▸ | DBF4 | Q9UBU7 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 2/20 | 0.34 |
| ▸ | KDM4E | B2RXH2 | 1/20 | 0.34 |
| ▸ | NPC1 | O15118 | 1/20 | 0.34 |
| ▸ | USP2 | O75604 | 1/20 | 0.34 |
| ▸ | MAPT | P10636 | 1/20 | 0.34 |
| ▸ | HPGD | P15428 | 1/20 | 0.34 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.34 |
| ▸ | SLC6A2 | P23975 | 1/20 | 0.33 |
| ▸ | HTT | P42858 | 1/20 | 0.33 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.33 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.33 |
| ▸ | HRH4 | Q9H3N8 | 1/20 | 0.33 |
| ▸ | TP53 | P04637 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL19039386 | 0.83 | LIMK1 (0.43) | LIMK1EGFRCDK5CDK5R1CDC7 | |
| SCHEMBL22627738 | 0.81 | KDM4E (0.37) | LIMK1EGFRCDK5CDK5R1CLK1 | |
| SCHEMBL24469186 | 0.78 | MAPT (0.42) | LIMK1EGFRCDK5CDK5R1CLK1 | |
| SCHEMBL24003242 | 0.77 | CYP1A2 (0.33) | ALDH1A1MAPTSLC6A2HTTCYP1A2 | |
| SCHEMBL22627556 | 0.77 | HTR1A (0.36) | ALDH1A1KDM4EMAPTSLC6A2HTT | |
| SCHEMBL19039387 | 0.76 | PSMD14 (0.49) | LIMK1ALDH1A1KDM4ENPC1MAPT | |
| SCHEMBL12846342 | 0.75 | PARP1 (0.44) | ALDH1A1KDM4ENPC1MAPTHPGD | |
| SCHEMBL8894268 | 0.75 | LIMK1 (0.65) | LIMK1EGFRCDK5CDK5R1HRH4 | |
| SCHEMBL29364650 | 0.72 | CYP1A2 (0.55) | ALDH1A1MAPTHPGDHSD17B10CYP1A2 | |
| SCHEMBL142551 | 0.72 | CYP1A2 (0.55) | ALDH1A1MAPTHPGDHSD17B10CYP1A2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230269999-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2023-08-24 | — | — | US | disclosed |
| US-20220372054-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2022-11-24 | — | — | US | disclosed |
| US-20200358008-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-12 | — | — | US | disclosed |
| US-20200350502-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | UNIVERSAL DISPLAY CORPORATION (US) | 2020-11-05 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20200350502-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | OSBP, OSBPL3, OSBP2 | LIMK1 518/4885EGFR 2339/4885CDK5 4500/4885 |
| US-20220372054-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ACAT1, SORD, CRAT | LIMK1 491/4885EGFR 2986/4885CDK5 2376/4885 |
| US-20230269999-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | ACAT1, ACMSD, SLC25A21 | LIMK1 951/4885EGFR 3555/4885CDK5 3505/4885 |
| US-20200358008-A1 | ORGANIC ELECTROLUMINESCENT MATERIALS AND DEVICES | L1CAM, EPCAM, SOD1 | LIMK1 101/4885EGFR 748/4885CDK5 3889/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.